| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer &EVP | Chief Technology Officer | See Remarks +1 more
1 company
Aunins John G. is a Chief Technology Officer &EVP at Seres Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $695K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2018 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sale+OE | 14,282 | $6.39 | $91,313.40 | -16.0% | |
| Nov 15, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sell | 14,279 | $8.26 | $117,911.70 | -13.8% | |
| Oct 15, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sell | 14,279 | $5.94 | $84,800.13 | -12.1% | |
| Sep 17, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sell | 42,837 | $7.64 | $327,344.65 | -9.7% | |
| Jul 15, 2018 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 14,279 | $8.10 | $115,725.58 | -8.1% | |
| Jun 15, 2018 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 14,279 | $8.57 | $122,325.34 | -7.7% | |
| Apr 25, 2018 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 14,279 | $7.58 | $108,266.23 | -7.2% | |
| Jan 26, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -0.9% | |
| Dec 19, 2017 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sale+OE | 1,623 | $10.14 | $16,457.22 | -2.7% | |
| Aug 29, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 9,390 | $10.87 | $102,069.30 | -4.7% |